V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20196295 | 20152462 | 1.68 | 64 | Palliative (P) | 2017-07-25 | 2017-07-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100543209 |
| 20196300 | 20152463 | 1.81 | 86 | 02 | 2015-11-06 | 2016-09-07 | Docetaxel | null | N | DOCETAXEL | 100623030 |
| 20196301 | 20152464 | 1.67 | 53.8 | null | null | 2018-01-08 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100430564 |
| 20196307 | 20152465 | 1.76 | 59.9 | null | 2017-04-02 | 2017-04-09 | CETUXIMAB + IRINOTECAN + MDG | 01 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101700200 |
| 20196308 | 20152466 | null | 95.9 | Palliative (P) | 2016-12-27 | 2016-12-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101223787 |
| 20196309 | 20152467 | 1.61 | 92 | Palliative (P) | 2016-06-24 | 2016-07-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100645619 |
| 20196318 | 20152468 | 1.79 | 77.6 | 03 | 2018-02-22 | 2018-03-14 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101653881 |
| 20196319 | 20152469 | 1.51 | 51.3 | Palliative (P) | 2019-07-26 | 2019-09-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100604560 |
| 20196326 | 20152470 | 1.67 | 85.4 | Palliative (P) | 2018-08-24 | 2018-08-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100744256 |
| 20196329 | 20152471 | 1.81 | 98 | null | 2016-10-31 | 2016-10-31 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100155574 |
| 20196335 | 20152472 | 1.88 | 40.2 | Palliative (P) | 2019-06-18 | 2019-06-20 | Docetaxel | 02 | N | DOCETAXEL | 100013456 |
| 20196343 | 20152473 | 1.74 | 77.6 | null | null | 2020-02-22 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100135053 |
| 20196348 | 20152474 | 1.84 | 80 | Adjuvant (A) | 2018-07-18 | 2018-08-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100631688 |
| 20196349 | 20152475 | 1.77 | 67.6 | Palliative (P) | 2016-08-27 | 2016-08-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101052484 |
| 20196352 | 20152476 | 1.83 | 87.9 | Palliative (P) | 2016-08-20 | 2017-04-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101783813 |
| 20196355 | 20152477 | 1.9 | 68 | null | 2022-02-26 | 2022-03-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100838472 |
| 20196358 | 20152478 | 1.88 | 65.4 | Palliative (P) | 2020-02-22 | 2020-12-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101806612 |
| 20196366 | 20152479 | 1.69 | 104 | null | 2019-04-26 | 2019-05-31 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101068736 |
| 20196370 | 20152480 | 1.79 | 86 | null | 2020-01-02 | 2020-02-11 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100677809 |
| 20196373 | 20152481 | null | 66.3 | Palliative (P) | 2017-09-10 | 2017-09-25 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100102800 |
| 20196376 | 20152482 | null | 43.6 | Palliative (P) | 2019-04-19 | 2019-11-25 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101820753 |
| 20196378 | 20152483 | 1.69 | 60.8 | null | 2016-09-09 | 2016-09-10 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100585661 |
| 20196384 | 20152484 | 1.74 | 61.6 | Palliative (P) | 2017-01-27 | 2017-02-07 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101096880 |
| 20196402 | 20152485 | 1.68 | 115.9 | Palliative (P) | 2019-10-29 | 2019-11-07 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100022340 |
| 20196406 | 20152486 | 1.74 | 65.8 | Palliative (P) | 2017-04-12 | 2017-04-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100865955 |
| 20196412 | 20152487 | 1.74 | 67.7 | null | 2017-04-09 | 2017-04-13 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100921389 |
| 20196417 | 20152488 | 1.68 | 67.2 | Palliative (P) | 2017-09-02 | 2017-09-10 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101299887 |
| 20196422 | 20152489 | 1.67 | 44.8 | null | 2019-02-16 | 2019-02-21 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100135700 |
| 20196424 | 20152490 | 1.74 | 71.6 | Palliative (P) | 2020-05-10 | 2020-06-07 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100854103 |
| 20196429 | 20152491 | 1.7 | 69.6 | Palliative (P) | 2016-11-10 | 2016-11-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100000349 |
| 20196430 | 20152492 | 1.9 | 66 | Palliative (P) | 2018-01-30 | 2018-02-02 | Docetaxel | 02 | N | DOCETAXEL | 100932751 |
| 20196436 | 20152493 | 2 | 62.9 | 03 | 2017-04-02 | 2017-04-10 | Docetaxel | 02 | N | DOCETAXEL | 101012856 |
| 20196437 | 20152494 | 1.61 | 70.45 | Palliative (P) | 2019-12-09 | 2019-12-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100427990 |
| 20196438 | 20152495 | 1.83 | 83.1 | null | 2016-05-10 | 2016-07-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101074379 |
| 20196442 | 20152496 | 1.85 | 50.4 | Palliative (P) | 2018-11-17 | 2018-11-26 | Docetaxel 75mg/m2 (21 day) | 2 | N | DOCETAXEL | 101390982 |
| 20196451 | 20152497 | 1.69 | 73.2 | null | 2017-07-25 | 2017-07-26 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101133338 |
| 20196457 | 20152498 | 1.61 | 62 | Palliative (P) | 2017-01-07 | 2017-02-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101693148 |
| 20196460 | 20152499 | 1.61 | 83.9 | Palliative (P) | 2018-08-03 | 2018-08-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101222930 |
| 20196462 | 20152500 | 1.61 | null | Palliative (P) | 2018-01-05 | 2018-01-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101337113 |
| 20196464 | 20152501 | 1.59 | 65 | Palliative (P) | 2020-02-10 | 2020-02-16 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101852219 |
| 20196468 | 20152502 | 1.61 | 88 | Palliative (P) | 2017-04-23 | 2018-03-19 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101614579 |
| 20196470 | 20152503 | 1.75 | 45.8 | null | 2018-02-19 | 2018-02-20 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100199702 |
| 20196471 | 20152504 | 1.91 | 68.5 | Palliative (P) | 2016-06-24 | 2016-07-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100509215 |
| 20196478 | 20152505 | 1.76 | 74 | Palliative (P) | 2016-11-07 | 2016-11-21 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101656441 |
| 20196481 | 20152506 | 1.85 | 35 | Palliative (P) | 2019-04-17 | 2019-04-23 | Docetaxel | 02 | N | DOCETAXEL | 100104437 |
| 20196482 | 20152507 | 1.7 | 68.2 | Palliative (P) | 2019-06-24 | 2019-07-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101595021 |
| 20196487 | 20152508 | 1.73 | 71.8 | null | 2017-12-12 | 2018-02-06 | Docetaxel | 02 | null | DOCETAXEL | 100255066 |
| 20196494 | 20152509 | 1.55 | 55.5 | Palliative (P) | 2018-02-23 | 2018-03-09 | Gemcitabine + Capecitabine | 99 | N | CAPECITABINE + GEMCITABINE | 100103938 |
| 20196495 | 20152510 | 1.7 | 83 | null | 2020-06-16 | 2021-03-28 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101228516 |
| 20196500 | 20152511 | 1.55 | 90.3 | Palliative (P) | 2016-10-04 | 2016-10-04 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100837250 |